Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Merck
McKinsey
Boehringer Ingelheim
Dow

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-three approved drugs.

There are two tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc
US Patents:0
Tradenames:51
Ingredients:49
NDAs:63

Drugs and US Patents for Actavis Labs Fl Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 076996-003 Apr 19, 2011 AB RX No No   See Pricing   See Pricing
Actavis Labs Fl Inc NITROFURANTOIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 091095-001 Jun 18, 2015 AB RX No No   See Pricing   See Pricing
Actavis Labs Fl Inc HYDROMORPHONE HYDROCHLORIDE hydromorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 202144-001 May 12, 2014 DISCN No No   See Pricing   See Pricing
Actavis Labs Fl Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 040220-002 Aug 29, 1997 AB RX No No   See Pricing   See Pricing
Actavis Labs Fl Inc OMEPRAZOLE omeprazole CAPSULE, DELAYED REL PELLETS;ORAL 075347-003 May 30, 2008 AB RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKesson
Medtronic
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.